Skip to Main Content

Paper Details

Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin.
Clin Genitourin Cancer
3
2022
Author NameAffiliation
Neeraj AgarwalUniversity of Utah
Jure MurgicUniversity Hospital Center Sestre Milosrdnice
Alexandra DrakakiDavid Geffen School of Medicine at university of california los angeles
Pedro Isaacsson VelhoSidney Kimmel Comprehensive Cancer Center
Evan Y YuUniversity of Washington, WA Clinical Research Division, Fred Hutchinson Cancer Research Center
Jonathan L WrightClinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington
  • 1 - 6

Datasets